U.S. Markets open in 3 hrs, 25 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,433.71 | -17.24 | -0.16% |
| NASDAQ | 2,169.18 | -6.83 | -0.31% |
| S&P 500 | 1,105.65 | -0.59 | -0.05% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 1.84 01:49 PM EST | |
|---|---|---|
| Day High | 1.92 02:20 PM EST |
|
| Range | 0.08 |
| Volume | 120,078 | |
|---|---|---|
| 30-Day Avg Vol | 202,000 |
|
| Difference | -40.56% |
| Market Cap | 126.05 M | |
|---|---|---|
| Mkt Cap Chg | 1.32 M |
| Shares Out | 66.34 M | |
|---|---|---|
| % Shrs Traded | 0.18% | |
| 1yr EPS Est | -0.54 |
| 52-Wk Low | 1.81 | |
|---|---|---|
| 52-Wk High | 6.82 |
|
| Range | 5.01 |
| Prev Close | 1.88 11/23/09 | |
|---|---|---|
| Today's Open | 1.88 | |
| Change | 0.00% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 1.28 M |
| Revenue (LFY) | 10.04 M | |
|---|---|---|
| Earnings (LFY) | -70.21 M | |
| Earnings (MRQ) | -11.67 M | |
| Next Earn Est | -0.19 | |
| Next Earnings | 02/15/2010 |
|
| EPS (TTM) | -0.93 | |
| 1yr EPS Growth | 42.55% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -3.00 | |
| PEG Ratio | — | |
| Return on Equity | -183.00 | |
| Beta | 0.52 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Idenix Pharmaceuticals is not suffering from any identity crisis -- it is clear in its focus on identifying treatments for life-threatening viruses. The biopharmaceutical firm is developing orally administered ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.19 2/15/10 | — — |
—
—
|
| Last Quarter | -0.236 9/30/09 | -0.18 9/30/09 |
0.056
Beat
|
| 2 Quarters Ago | -0.25 6/30/09 | -0.28 6/30/09 |
-0.03
Missed
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 3.11 M | 10.05 M |
| Gross Profit | 1.51 M | -45.58 M |
| Operating Income | -12.00 M | -72.71 M |
| Net Income | -11.67 M | -70.21 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts